Published in Br J Pharmacol on February 01, 2012
The vascular endothelium and human diseases. Int J Biol Sci (2013) 1.49
Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension (2011) 0.97
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity. Hypertension (2012) 0.95
Shear stress and atherosclerosis. Mol Cells (2014) 0.92
Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries. Pflugers Arch (2013) 0.88
Regulation of vascular smooth muscle tone by adipose-derived contracting factor. PLoS One (2013) 0.88
Obesity suppresses circulating level and function of endothelial progenitor cells and heart function. J Transl Med (2012) 0.87
Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol (2015) 0.82
Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice. Biochim Biophys Acta (2013) 0.78
Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice. PLoS One (2015) 0.77
Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice. PLoS One (2012) 0.77
Obesity causes lymphatic vascular injury: time for clinical translation. J Physiol (2016) 0.75
Association of sleep apnea and sleep duration with peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2016) 0.75
TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice. Cardiovasc Diabetol (2016) 0.75
Obesity and vascular dysfunction: the fat-e of rich and poor. Br J Pharmacol (2012) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
A potential decline in life expectancy in the United States in the 21st century. N Engl J Med (2005) 19.63
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 9.93
Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (2009) 9.84
Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med (2007) 8.84
NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res (2000) 8.62
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77
Obesity-induced inflammatory changes in adipose tissue. J Clin Invest (2003) 7.50
Endothelium-derived relaxing and contracting factors. FASEB J (1989) 7.22
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science (1973) 6.38
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
Diet-induced type II diabetes in C57BL/6J mice. Diabetes (1988) 6.26
Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation (2006) 5.91
Adolescent overweight and future adult coronary heart disease. N Engl J Med (2007) 5.74
Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med (2009) 5.64
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol (1986) 4.88
The public health impact of obesity. Annu Rev Public Health (2001) 4.83
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Dietary fat intake does affect obesity! Am J Clin Nutr (1998) 4.26
EDHF: bringing the concepts together. Trends Pharmacol Sci (2002) 3.69
Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol (2009) 3.09
Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav (2004) 3.00
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol (2006) 2.97
Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science (2010) 2.93
Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res (1982) 2.76
Economic costs of obesity and inactivity. Med Sci Sports Exerc (1999) 2.71
Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) (2009) 2.67
Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab (2007) 2.48
The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging. Obesity (Silver Spring) (2010) 2.43
Avosentan for overt diabetic nephropathy. J Am Soc Nephrol (2010) 2.32
Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: a prospective study among United States adults. Circulation (2010) 2.29
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension (1994) 2.28
Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord (2004) 2.27
Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes (2010) 2.19
Medicine. Beige can be slimming. Science (2010) 2.17
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res (2009) 2.16
Childhood obesity--the shape of things to come. N Engl J Med (2007) 2.09
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. J Am Soc Nephrol (2011) 2.07
Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation (2000) 1.97
Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol (1985) 1.97
Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res (2001) 1.94
Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension (2010) 1.91
The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol (2005) 1.88
Visceral adipose tissue modulates mammalian longevity. Aging Cell (2008) 1.87
Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol (2006) 1.81
Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens (2002) 1.77
Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun (1997) 1.76
Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol (2011) 1.76
Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol (2008) 1.69
Biology of the endothelium. Clin Cardiol (1997) 1.68
Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J (2009) 1.65
Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61
Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J Proteome Res (2009) 1.59
Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A (2003) 1.56
Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol (2006) 1.56
NADPH oxidases in cardiovascular disease. Free Radic Biol Med (2010) 1.53
Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord (2004) 1.51
Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant (2010) 1.50
Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) (2011) 1.48
Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes (2001) 1.46
Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res (2003) 1.44
Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension (1997) 1.41
The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med (2010) 1.37
Endothelial cells in culture produce a vasoconstrictor substance. J Cell Physiol (1987) 1.31
Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics (2007) 1.27
Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler Thromb Vasc Biol (2010) 1.25
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag (2009) 1.22
Postmenopausal hypertension: mechanisms and therapy. Hypertension (2009) 1.22
Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett (1998) 1.20
Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/- knockout but not COX1-/- knockout mice. J Cardiovasc Pharmacol (2005) 1.19
Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf) (2010) 1.18
Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture. J Pharmacol Exp Ther (1986) 1.17
Reversal of proteinuric renal disease and the emerging role of endothelin. Nat Clin Pract Nephrol (2008) 1.16
The impact of symptoms and impairments on overall health in US national health data. Med Care (2008) 1.11
Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension (1997) 1.10
Recognition and management of overweight and obesity in primary care in Germany. Int J Obes Relat Metab Disord (2004) 1.09
Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res (2007) 1.08
Endothelium-dependent contractions: when a good guy turns bad! J Physiol (2008) 1.08
Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels. Am J Cardiol (2010) 1.05
Overweight and sympathetic overactivity in black Americans. Hypertension (2001) 1.04
The multiple facets of the fat tissue. Thyroid (2008) 1.04
Obesity rising to alarming levels around the world. Lancet (2002) 1.04
Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch (2010) 1.04
Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension (2003) 1.03
Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res (2006) 1.01
Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension (2000) 1.01
Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight. Diabetes (2010) 1.00
The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol (2011) 1.00
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One (2009) 0.99
COX-mediated endothelium-dependent contractions: from the past to recent discoveries. Acta Pharmacol Sin (2010) 0.99
The economics of diabetes prevention. Med Clin North Am (2011) 0.99
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res (2009) 2.16
Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension (2007) 1.64
Postmenopausal hypertension: mechanisms and therapy. Hypertension (2009) 1.22
Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology (2010) 1.17
Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? Arterioscler Thromb Vasc Biol (2007) 0.96
ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res (2009) 0.86
Estrogen-independent activation of estrogen receptors. Hypertension (2011) 0.79
Testosterone and secondary hypertension: new pieces to the puzzle. Hypertension (2012) 0.77
Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. J Cardiovasc Pharmacol (2013) 0.76
Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis. Sci Rep (2015) 0.76
Lung cancer and hormone replacement therapy. Lancet (2010) 0.75